EPFL Innovation Park
17 articles with Sophia Genetics
SOPHiA GENETICS, a leading health tech company, announced today the closing of a $77 million investment round to accelerate the democratization of Data-Driven Medicine.
Paragon Genomics Partners Its Ultra-High Multiplexed Target Enrichment Technology With SOPHiA GENETICS For Comprehensive Genomic Solutions
Universal SOPHiA AI Platform Now Includes Paragon Genomics' Accurate and Sensitive CleanPlex® NGS Target Enrichment Technology for Its Rapidly-Growing Global Community of Cancer Centers
SOPHiA GENETICS Presents Alamut Genova, the Latest Evolution of the Alamut Software for Genomic Variant Exploration
SOPHiA GENETICS, leader in Data-Driven Medicine, has announced today from the annual meeting of the American Society of Human Genetics (ASHG), the release of Alamut Genova, the advanced variant exploration software for genomic data visualization and interpretation.
SOPHiA AI (SOPHiA) is the most widely used technology for genomic analysis, adopted by hundreds of university hospitals worldwide.
SOPHiA GENETICS Acquires Interactive Biosoftware to Drive Growth and Accelerate Data-Driven Medicine Adoption Around the World
SoPHiA GENETICS, announced today at the European Human Genetics Conference (ESHG 2018) that it has completed the acquisition of French-based tech company Interactive Biosoftware (IBS).
Here is a look at the life science companies viewed as the most innovative in the world.
Matillon brings over twenty years of experience in senior financial management positions in leading technology organizations, including SITA, Hewlett-Packard and Electronic Arts.
Horizon Discovery Ltd. Partners With Sophia Genetics On NGS Reference Standards For Oncology Applications
Sophia Genetics Unveils SOPHiA, The World’s Most Advanced Collective Artificial Intelligence For Data-Driven Medicine
Sophia Genetics And Integrated DNA Technologies Partner To Create NGS Solutions In Routine Clinical Diagnostics
Sophia Genetics Receives CE-IVD Mark For Genetic Testing Of Familial Mediterranean Fever And Hypercholeteromia
Sophia Genetics Announces First Deal With Britain's NHS And Leading Turkish Laboratory, Expanding European Customer Base
Sophia Genetics Becomes The First European Company To Obtain CE-IVD Mark For Clinical Use Of Next Generation Sequencing Bioinformatics Pipeline For Routine Genetic Testing